PAA 4.26% 22.5¢ pharmaust limited

Ann: Board Changes, page-180

  1. 1,068 Posts.
    lightbulb Created with Sketch. 85
    Hi Pete, just a few extra bits of info ….

    Relyvrio, were on track for 10,000 patient level in the USA. They reached approx 1/3 of that.

    The annual price was approx us$160,000 per patient.

    Thats us$1.6b revenue annually.

    I think you’re undercooking it a bit, put the risk / chance of success in the discount rate or multiple, not on the cash flows.

    However, great initiative & thx, all indications point to significant value accretion, we’re only arguing over magnitude.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
-0.010(4.26%)
Mkt cap ! $89.08M
Open High Low Value Volume
23.5¢ 23.5¢ 22.0¢ $170.5K 749.0K

Buyers (Bids)

No. Vol. Price($)
2 34313 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 24444 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
22.5¢
  Change
-0.010 ( 6.25 %)
Open High Low Volume
23.0¢ 23.0¢ 22.0¢ 246904
Last updated 15.57pm 14/06/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.